Skip to main content
logo
Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.410
+0.090 (6.82%)
At close: Apr 6, 2026, 4:00 PM EDT
1.400
-0.010 (-0.71%)
Pre-market: Apr 7, 2026, 4:00 AM EDT

Marker Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
242533492279
Market Cap Growth
109.90%-25.41%-31.90%118.95%-71.68%7.21%
Enterprise Value
7.448.7714.1133.7910.5547.76
Last Close Price
1.411.493.115.502.669.50
PE Ratio
--1.89-2.61-5.85-0.74-1.74
PS Ratio
6.637.005.0514.772.4863.51
PB Ratio
1.401.481.793.481.141.79
P/TBV Ratio
1.281.361.513.451.131.65
P/FCF Ratio
--2.07-3.05-2.97-0.70-2.59
P/OCF Ratio
--2.07-3.05-2.97-0.83-2.89
EV/Sales Ratio
2.102.472.1410.211.1738.47
EV/EBITDA Ratio
--0.68-1.27-2.32-0.40-1.32
EV/EBIT Ratio
--0.68-1.27-2.32-0.35-1.21
EV/FCF Ratio
--0.73-1.29-2.06-0.33-1.57
Debt / Equity Ratio
-00000.26
Debt / EBITDA Ratio
------0.33
Debt / FCF Ratio
------0.39
Net Debt / Equity Ratio
-0.96-0.96-1.03-1.07-0.60-0.69
Net Debt / EBITDA Ratio
1.251.251.731.040.450.84
Net Debt / FCF Ratio
1.341.341.760.920.371.00
Asset Turnover
0.170.170.340.130.180.02
Quick Ratio
7.677.676.225.251.823.28
Current Ratio
8.398.396.365.572.143.56
Return on Equity (ROE)
-68.89%-68.81%-65.81%-83.47%-94.14%-117.42%
Return on Assets (ROA)
-62.66%-62.66%-57.06%-56.59%-58.40%-69.41%
Return on Invested Capital (ROIC)
-926.20%-926.20%-1658.29%-143.07%-172.26%-240.00%
Return on Capital Employed (ROCE)
-72.92%-72.92%-68.19%-71.67%-73.15%-83.60%
Earnings Yield
-51.74%-53.02%-38.26%-17.09%-134.64%-57.57%
FCF Yield
-51.10%-48.36%-32.76%-33.62%-142.90%-38.56%
Buyback Yield / Dilution
-70.49%-70.49%-1.94%-5.49%-9.16%-62.64%
Total Shareholder Return
-70.49%-70.49%-1.94%-5.49%-9.16%-62.64%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q